Preliminary results of a phase II trial on targeted therapy with cetuximab in EGFR-expressing adenoid cystic carcinoma of the oral cavity

被引：0
|
作者：
Hitre, Erika [1 ]
Boer, Andras [1 ]
Remenar, Eva [1 ]
Takacsi-Nagy, Zoltan [1 ]
Godeny, Maria [1 ]
Kasler, Miklos [1 ]
Lang, Istvan [1 ]
机构：
[1] Natl Inst Oncol, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [41] Phase II trial of gemcitabine-UFT-leucovorin (ILV) in advanced carcinoma of the pancreas:: Preliminary results
    Feliu, J
    Vincent, JM
    Dorta, J
    Constenla, M
    Espinosa, J
    Belón, J
    López-Gómez, L
    Fernández, Y
    de Castro, J
    Barón, MG
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S156 - S157
  • [42] High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial
    Bush, DA
    Hillebrand, DJ
    Slater, JM
    Slater, JD
    GASTROENTEROLOGY, 2004, 127 (05) : S189 - S193
  • [43] A phase II study of lapatinib in recurrent or metastatic EGFR and/or ErbB2 expressing adenoid cystic (ACC) and non-ACC malignant tumors of the salivary glands (MSGT).
    Agulnik, M.
    Cohen, E. E.
    Cohen, R. B.
    Chen, E. X.
    Hotte, S. J.
    Winquist, E.
    Laurie, S.
    Hayes, D. N.
    Dancey, J. E.
    Siu, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 296S - 296S
  • [44] Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma.
    Ho, Alan Loh
    Foster, Nathan R.
    Meyers, Jeffrey P.
    Vasudeva, Shyamprasad Deraje
    Katabi, Nora
    Antonescu, Cristina R.
    Pfister, David G.
    Horvath, Laura E.
    Erlichman, Charles
    Schwartz, Gary K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Preliminary data from a phase II study of cetuximab with irinotecan in heavily pretreated patients with epidermal growth factor (EGFR)-expressing metastatic colorectal cancer (mCRC): LABEL
    Buzaid, A.
    de Cerqueira Mathias, C.
    Perazzo, F.
    Simon, S.
    Fein, L.
    Hidalgo, J.
    Murad, A. M.
    Esser, R.
    Loos, A.
    Lerzo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
    Kies, Merrill S.
    Holsinger, Floyd Christopher
    Lee, J. Jack
    William, William N., Jr.
    Glisson, Bonnie S.
    Lin, Heather Y.
    Lewin, Jan S.
    Ginsberg, Lawrence E.
    Gillaspy, Katharine A.
    Massarelli, Erminia
    Byers, Lauren
    Lippman, Scott M.
    Hong, Waun K.
    El-Naggar, Adel K.
    Garden, Adam S.
    Papadimitrakopoulou, Vassiliki
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 8 - 14
  • [47] Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study
    Chang, Peter Mu-Hsin
    Lu, Hsueh-Ju
    Wang, Ling-Wei
    Tai, Shyh-Kuan
    Chen, Ming-Huang
    Chu, Pen-Yuan
    Yang, Muh-Hwa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (07): : 1333 - 1342
  • [48] Cetuximab as first-line monotherapy in patients with unresectable squamous cell carcinoma of the skin: Preliminary results of a phase II multicenter study
    Maubec, E.
    Petrow, P.
    Duvillard, P.
    Certain, A.
    Duval, X.
    Kerob, D.
    Bagot, M.
    Faivre, S.
    Mentre, F.
    Avril, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Neoadjuvant chemoradiotherapy with 5-fluorouracil-cisplatin combined with cetuximab in patients with resectable locally advanced esophageal carcinoma: A prospective phase I/II trial (FFCD-PRODIGE 3)-Preliminary phase II results
    Dahan, Laetitia
    Mariette, Christophe
    Ychou, Marc
    Tan Dat Nguyen
    Guimbaud, Rosine
    Aparicio, Thomas
    Vendrely, Veronique
    d'Journo, Xavier
    Subtil, Fabien
    Bonnetain, Franck
    Adenis, Antoine
    Seitz, Jean Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase II trial of ixabepilone (IXA) plus cetuximab (C) as first-line therapy for advanced pancreatic carcinoma (PC)
    Lima, C. S. Roche
    Lin, E. H.
    Kim, G. P.
    Giguere, J. K.
    Marshall, J.
    Zalupski, M.
    Papageorgio, C. N.
    Auber, M. L.
    McHenry, M. B.
    Philip, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345